BANK OF AMERICA CORP /DE/ - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 213 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.5%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$33,697,923
-13.2%
885,855
+108.0%
0.00%0.0%
Q2 2023$38,803,316
-3.2%
425,942
-29.9%
0.00%0.0%
Q1 2023$40,086,199
+65.3%
607,735
+29.6%
0.00%
+33.3%
Q4 2022$24,252,612
-48.7%
469,012
-32.2%
0.00%
-50.0%
Q3 2022$47,256,000
+183.7%
691,877
+87.8%
0.01%
+200.0%
Q2 2022$16,655,000
-14.2%
368,316
-3.6%
0.00%0.0%
Q1 2022$19,406,000
+49.3%
381,958
+38.9%
0.00%
+100.0%
Q4 2021$12,998,000
-26.4%
274,906
-48.7%
0.00%
-50.0%
Q3 2021$17,656,000
+16.2%
535,672
+122.8%
0.00%0.0%
Q2 2021$15,192,000
-1.1%
240,379
-32.9%
0.00%0.0%
Q1 2021$15,361,000
+77.1%
357,979
+136.1%
0.00%
+100.0%
Q4 2020$8,673,000
+131.9%
151,625
+22.3%
0.00%0.0%
Q3 2020$3,740,000
-35.9%
123,944
-30.6%
0.00%0.0%
Q2 2020$5,835,000
+2.2%
178,641
-16.2%
0.00%0.0%
Q1 2020$5,710,000
-4.3%
213,120
+9.3%
0.00%0.0%
Q4 2019$5,968,000
+66.1%
194,901
+30.6%
0.00%0.0%
Q3 2019$3,594,000
-29.5%
149,191
-25.9%
0.00%0.0%
Q2 2019$5,100,000
+35.7%
201,270
+4.5%
0.00%0.0%
Q1 2019$3,757,000
+1526.4%
192,627
+998.7%
0.00%
Q4 2018$231,000
+83.3%
17,533
+146.0%
0.00%
Q3 2018$126,000
-72.9%
7,126
-66.3%
0.00%
Q2 2018$465,000
+1921.7%
21,147
+1914.0%
0.00%
Q1 2018$23,000
-23.3%
1,050
-23.9%
0.00%
Q4 2017$30,0001,3800.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,130,000$119,065,20018.29%
EcoR1 Capital, LLC 10,899,859$414,630,63613.99%
Ally Bridge Group (NY) LLC 181,805$6,915,8628.12%
Avoro Capital Advisors LLC 11,111,111$422,666,6626.59%
ACUTA CAPITAL PARTNERS, LLC 244,484$9,300,1716.23%
Iron Triangle Partners LP 880,000$33,475,2004.89%
Cormorant Asset Management, LP 2,000,000$76,080,0004.44%
Octagon Capital Advisors LP 675,000$25,677,0003.94%
Logos Global Management LP 750,000$28,530,0003.81%
Boxer Capital, LLC 1,726,000$65,657,0403.50%
View complete list of APELLIS PHARMACEUTICALS INC shareholders